ADC Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2017
Revenue	70.84	69.56	209.91	33.92	-	Upgrade
Revenue Growth (YoY)	1.84%	-66.86%	518.89%	-	-	Upgrade
Cost of Revenue	115.58	129.66	189.76	159.4	141.82	Upgrade
Gross Profit	-44.75	-60.1	20.15	-125.48	-141.82	Upgrade
Selling, General & Admin	85.91	105.89	143.49	136.24	77.23	Upgrade
Operating Expenses	85.91	105.89	143.49	136.24	77.23	Upgrade
Operating Income	-130.65	-165.99	-123.34	-261.72	-219.05	Upgrade
Interest Expense	-50.21	-46.33	-36.73	-18.34	-4.93	Upgrade
Interest & Investment Income	12.27	10.54	2.57	0.07	0.83	Upgrade
Earnings From Equity Investments	-1.54	-5.53	-10.08	-6.67	24.37	Upgrade
Currency Exchange Gain (Loss)	-0.08	-0.05	-0.11	0.05	-0.58	Upgrade
Other Non Operating Income (Expenses)	12.54	6.4	52.91	35.11	-46.4	Upgrade
EBT Excluding Unusual Items	-157.68	-200.95	-114.79	-251.51	-245.75	Upgrade
Asset Writedown	-	-	-	-	-0.22	Upgrade
Other Unusual Items	-	-	-42.11	-	-	Upgrade
Pretax Income	-157.68	-200.95	-156.9	-251.51	-245.96	Upgrade
Income Tax Expense	0.17	39.11	0.23	-21.48	0.33	Upgrade
Net Income	-157.85	-240.05	-157.13	-230.03	-246.29	Upgrade
Net Income to Common	-157.85	-240.05	-157.13	-230.03	-246.29	Upgrade
Shares Outstanding (Basic)	97	82	78	77	65	Upgrade
Shares Outstanding (Diluted)	97	82	78	77	65	Upgrade
Shares Change (YoY)	18.91%	4.55%	1.83%	17.33%	32.73%	Upgrade
EPS (Basic)	-1.62	-2.94	-2.01	-3.00	-3.77	Upgrade
EPS (Diluted)	-1.62	-2.94	-2.01	-3.00	-3.77	Upgrade
Free Cash Flow	-124.7	-121.9	-139	-236.81	-169.53	Upgrade
Free Cash Flow Per Share	-1.28	-1.49	-1.78	-3.09	-2.59	Upgrade
Gross Margin	-63.17%	-86.40%	9.60%	-	-	Upgrade
Operating Margin	-184.44%	-238.63%	-58.76%	-771.65%	-	Upgrade
Profit Margin	-222.83%	-345.11%	-74.86%	-678.20%	-	Upgrade
Free Cash Flow Margin	-176.04%	-175.25%	-66.22%	-698.20%	-	Upgrade
EBITDA	-129.32	-164.8	-122.28	-260.75	-218.23	Upgrade
EBITDA Margin	-182.56%	-236.92%	-58.26%	-	-	Upgrade
D&A For EBITDA	1.33	1.19	1.06	0.97	0.82	Upgrade
EBIT	-130.65	-165.99	-123.34	-261.72	-219.05	Upgrade
EBIT Margin	-184.44%	-238.63%	-58.76%	-	-	Upgrade
Revenue as Reported	70.84	69.56	209.91	33.92	-	Upgrade

Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q